SavedAdd your journal

Journals / Bozok Tıp Dergisi / 2015 / Cilt: 5 - Sayı: 4

The Prevalence of Thrombophilic Mutations in Geriatric Patients With Deep Venous Thrombosis

DERİN VEN TROMBOZU OLAN YAŞLI HASTALARDA TROMBOFİLİK MUTASYONLARIN SIKLIĞI

Meral EKİM
Zeynep Tuğba ÖZDEMiR
Yunus Keser YILMA
Hasan EKİM
Pages
49–55
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Alsoelderly patients taking coumadin are more likely to have fluctuating levels of anticoagulation, biochemicalparameters should be monitored at more frequent intervals to maintain appropriate treatment and to avoidpossible complications in geriatric patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Deep venous thrombosis (DVT) is predominantly disorder of older age and its incidence increasesexponentially with age.
📊
Key Findings & Data:Our aim was to investigate the frequency of genetic mutationsin elderly patients with DVT admitted to our hospital Material and Methods: A total of 25 geriatric patients with DVT admitted to our clinic, between April 2013and February 2015 were investigated for factor V Leiden (FVL), prothrombin gene mutation (PT G20210A),and methylenetetrahydrofolate reductase (MTHFR) mutations (C677T, A1298C).
💡
Conclusion & Impact:Alsoelderly patients taking coumadin are more likely to have fluctuating levels of anticoagulation, biochemicalparameters should be monitored at more frequent intervals to maintain appropriate treatment and to avoidpossible complications in geriatric patients.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Deep venous thrombosis (DVT) is predominantly disorder of older age and its incidence increasesexponentially with age. The pathogenesis of venous thrombosis is multifactorial and needs the interactionbetween hereditary and acquired risks factors. Our aim was to investigate the frequency of genetic mutationsin elderly patients with DVT admitted to our hospital Material and Methods: A total of 25 geriatric patients with DVT admitted to our clinic, between April 2013and February 2015 were investigated for factor V Leiden (FVL), prothrombin gene mutation (PT G20210A),and methylenetetrahydrofolate reductase (MTHFR) mutations (C677T, A1298C). Screening of polymorphismswas carried out by using SNaPshot® multiplex system (Applied Biosystems Inc.). Also, biochemical parametersrelated to anticoagulant therapy were monitored closely. Results: There were 18 male and 7 female patients ranging in age from 65 to 87 years, with a mean ageof 70.52±6.21 years. FVL mutation was found in 11 (44%) patients (2 homozygotes, 9 heterozygotes), therewas 1 (4%) patient with heterozygous PT G20210A mutation, MTHFR C677T was found in 10 (40%) patients(1 homozygote, 9 heterozygotes), and MTHFR A1298C was found in 14 (56%) patients (3 homozygotes, 11heterozygotes). Fluctuating levels of anticoagulation were observed in most geriatric patients. Conclusion: Inherited mutations among the geriatric patients with DVT are not rare. Therefore, we suggestthat every geriatric patient with DVT should be screened for the FVL, PT G20210A and MTHFR mutations. Alsoelderly patients taking coumadin are more likely to have fluctuating levels of anticoagulation, biochemicalparameters should be monitored at more frequent intervals to maintain appropriate treatment and to avoidpossible complications in geriatric patients.

Özet

Amaç: Derin ven trombozu (DVT) ileri yaşta predominant olan bir rahatsızlık olup, insidansı yaşla katlanarak artar. Kalıtsal ve edinsel risk faktörleri arasında etkileşim gerektiğinden patogenezinde birçok etkenin rolüvardır. Amacımız, hastanemize başvuran DVTli yaşlı hastalarda genetik mutasyonların sıklığını araştırmaktır.Gereç ve Yöntemler: Nisan 2013 ile Şubat 2015 tarihleri arasında DVT tanısıyla kliniğimize kabul edilen 25geriatrik hastada faktör V Leiden (FVL), protrombin gen mutasyonu (PT G20210A) ve metilentetrahidrofolatredüktaz (MTHFR) mutasyonları (C677T, A1298C) araştırıldı. Polimorfizm taranması SNaPshot® multipleks sistemi (Applied Biosystems A.Ş.) kullanılarak gerçekleştirildi. Ayrıca, antikoagülan tedavi ile ilgili biyokimyasalparametreler yakından takip edildi.Bulgular: Hastalarımızın yedisi kadın, 18i erkekti ve yaşları 65 ile 86 arasında değişmekte ortalama yaş da70.52±6.21 yıl idi. FVL mutasyonu 11 (%44) hastada (2 homozigot, heterozigot 9) ve heterozigot PT G20210Amutasyonu 1 (%4) hastada tespit edildi. MTHFR C677T mutasyonu 10 (%40) hastada (1 homozigot, 9 heterozigot) ve MTHFR A1298C mutasyonu 14 (%56) hastada (3 homozigot, 11 heterozigot) tespit edildi.Sonuç: DVT tanısı konulan geriatrik hastalarda kalıtsal mutasyonlar nadir değildir. Bundan dolayı, DVT tanısıalan her geriatrik hasta FVL, PT G20210A ve MTHFR mutasyonları için taranmalıdır. Ayrıca, coumadin kullananyaşlı hastalarda antikoagülasyon seviyelerindeki dalgalanmalar daha sık olduğundan biyokimyasal parametreler uygun tedaviyi sürdürmek ve olası komplikasyonlardan kaçınmak için daha sık aralıklarla izlenmelidir.

🔖

Cite This Article

EKİM, M., ÖZDEMiR, Z. T., YILMA, Y. K., EKİM, H. (2022). The Prevalence of Thrombophilic Mutations in Geriatric Patients With Deep Venous Thrombosis. Bozok Tıp Dergisi, Cilt: 5 - Sayı: 4, 49–55. https://ajindex.com/articles/468856

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Doruk H, Naharcı Mİ, Safer U, Bozoğlu E, Taşçı İ. Yaşlılarda derin ven trombozu. Akad Geriatri 2012;4(1):69-77
  2. Weill-Engerer S, Meaume S, Lablou A, Piette F, Saint-Jean O, Sachet A, et al. Risk factors for deep vein thrombosis in inpatients aged 65 and older: A case-control multicenter study.J Am Geriatr Soc 2004;52(10):1299-304
  3. İbrişim E, Öcal A, Yavuz T, Kutsal A. Yaşlılarda derin ven trombozu. Geriatri 1999;2(2):160-2
  4. Reardon G, Pandy N, Nutescu AE, Lamori J, Damaraju CV, Schein J, et al. Incidence of venous thromboembolism in nursing home residents. JAMDA 2013;14(6):578-84
  5. Stein PD, Beemath A, and Olson RE. Trends in the incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients. Am J Cardiol 2005;95(16):1525-6
  6. Hong KC, Kim H, Kim JY, Kwak KS, Cho OM, Cha HY, et al. Risk factors and incidence of deep vein thrombosis in lower extremities amaong critically ill patients. J Clin Nurse 2012;21(13):1840-6
  7. Dahlback B, Carlsson M, and Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90(10):1004-8
  8. Gupta V. Inherited hypercoagulable disorders in the elderly. Geriatric 2003;6(4):13-5
  9. Kreidy R, Irani_Hakime N. Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients? Vasc Health Risk manag 2009;5(6):627-33
  10. Fidancı ŞB, Yaroğlu HY, Ünal N, Güneş G, Sert GA, Sucu N, et al. Venöz tromboz ön tanısı olan hastalarda Faktör V leiden, Protormbin G20210A, MTHFR C677T and MTHFR A1298C mutasyonlarının dağılımı. Mersin Univ Saglık Bilim Derg 2010;3(3):30-4
  11. Akar N, Mısırlıoğlu, Akar E, Avcu F, Yalçın A, and Sözüöz A. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 1998;58(3):249
  12. Hotoleanu C, Trifa A, Popp R, Fodor D. The importance of homozygous polymorphisms of methylenetetrahydrofolate reductase gene in Romanian patients with idiopathic venous thromboembolism. Balkan Med J 2013;30(2):197-203 13. Şahin Ş, Benli I, Aydoğan L. Distribution of prothrombin G20210A, factor V Leiden, and MTHFR C677T mutations in the middle black sea area (Tokat) of Turkey. Turk J Med Sci 2012;42(11);1093-7
  13. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, et al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembo